Thomas Jantsch

Chief Financial Officer at EyeVerify, Inc.

Thomas Jantsch

Thomas Jantsch

Chief Financial Officer at EyeVerify, Inc.

Overview
Career Highlights

EyeVerify, Inc.
Evogen, Inc.

RelSci Relationships

975

Number of Boards

1

Relationships
RelSci Relationships are individuals Thomas Jantsch likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at EyeVerify, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at SAGE Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & President at New Sapience, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Evogen, Inc.

Relationship likelihood: Strong

Co-Founder at Think Big Ventures

Relationship likelihood: Strong

Director-Computational Intelligence at University of Missouri - Kansas City

Relationship likelihood: Strong

Executive Vice President-Global Sales & Marketing at EyeVerify, Inc.

Relationship likelihood: Strong

Vice President-Engineering at EyeVerify, Inc.

Relationship likelihood: Strong

Executive Chairman at PlusN LLC

Relationship likelihood: Average

Former President & Chief Executive Officer at MRIGlobal

Relationship likelihood: Average

Paths to Thomas Jantsch
Potential Connections via
Relationship Science
You
Thomas Jantsch
Chief Financial Officer at EyeVerify, Inc.
Career History
Chief Financial Officer
Current

EyeVerify, Inc. provides software that brings to market an authentication module that utilizes cameras on mobile devices. Its product include Eyeprint ID which opens mobile devices, logs you into apps, and secures your mobile payments. The company was founded by Reza Derakhshani and Toby Rush on January 1, 2012 and is headquartered Lenexa, KS.

President & Chief Executive Officer
Prior

Evogen is a global biological detection system company, and is the leading developer and manufacturer of High Definition PCR™ (HD PCR) molecular diagnostics systems, meeting the needs of a diverse range of markets including biodefense, clinical, research, animal health, agbio, food and water safety, indoor air quality, environmental monitoring and forensics.Through its core expertise and patented technologies in the collection, concentration, preparation and detection of clinical and environmental biological samples, the company have developed product offerings that range from stand-alone modules and assay kits through to fully integrated units for dedicated diagnostic tasks. The company are developing both semi- and fully-automated rapid HD PCR diagnostic systems and Automated Sample Preparation (ASP) technology for sample preparation.

Transactions
Details Hidden

Evogen, Inc. raised money in a private placement transaction

Other Affiliations

Thomas Jantsch is affiliated with EyeVerify, Inc., Evogen, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thomas Jantsch. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thomas Jantsch's profile does not indicate a business or promotional relationship of any kind between RelSci and Thomas Jantsch.